NewsAAAAI: Omalizumab as Effective as Multifood Oral Immunotherapy for Individuals With Food AllergyHealthDay.comMarch 6, 2026
NewsAAOS: GLP-1 Receptor Agonist Use Increases Five-Year Risk for OsteoporosisHealthDay.comMarch 6, 2026
NewsSubset of Patients With Follicular Lymphoma Can Achieve Cure With CHOP-Based ChemoimmunotherapyHealthDay.comMarch 6, 2026
Cartoon GalleryMEME: Patient says, “I was supposed to take how many?”Jason MendelsohnJanuary 25, 2019
